Obesity
From the Journals
Look beyond liver biopsy for NAFLD diagnosis
A new study showed that many patients with advanced disease have not undergone liver biopsy, which some studies include biopsy among their...
From the Journals
AGA Clinical Practice Guidelines: Intragastric balloons in the management of obesity
Although older models of intragastric balloons could have “devastating adverse events” that led to their removal from market in the 1980s and...
From the Journals
Bariatric surgery may cut cancer in obesity with liver disease
Among working adults with severe obesity and fatty liver disease, rates of cancer were lower after bariatric surgery during a 10-month median...
From the Journals
Pediatric NAFLD almost always stems from excess body weight, not other etiologies
Just 2% of children with overweight or obesity and suspected NAFLD had other causes of liver disease.
From the Journals
AGA Clinical Practice Update: Bariatric surgery in patients with cirrhosis
Obesity heightens risks of portal vein thrombosis, portal hypertension, hepatocellular carcinoma, and liver failure in acute on chronic liver...
Feature
Widespread liver disease missed in patients with T2D
New evidence showing how common fatty liver disease and fibrosis are in patients with type 2 diabetes triggers a broadened “call to action.”
From the Journals
Teenage bone density declines following sleeve gastrectomy
These patients may never reach peak bone mass.
From the AGA Journals
Endoscopic intragastric balloon improved NASH parameters
At 6 months, nonalcoholic fatty liver disease activity scores had improved in 18 of 20 biopsied patients (90%), with a median decrease of 3 points...
From the AGA Journals
Autologous fecal microbiota transplantation helped maintain weight loss after ‘green’ Mediterranean diet
Eight months after the “green” diet ended, 17% of individuals in the autologous fecal microbiota transplantation group had regained weight,...
Conference Coverage
Obesity phenotyping matches patients with more effective interventions
A prospective, randomized study suggests obesity phenotyping can guide selection of more effective, tailored weight-loss drug regimens.